United Services Automobile Association Syndax Pharmaceuticals Inc Transaction History

United Services Automobile Association

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$7.47 - $10.76 $923,912 - $1.33 Million	-123,683 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$4.9 - $9.31 $5,537 - $10,520	1,130 Added 0.92%	123,683 $1.15 Million
Q4 2018 Feb 13, 2019	SELL	$3.6 - $8.42 $14,796 - $34,606	-4,110 Reduced 3.24%	122,553 $545,000
Q2 2018 Aug 10, 2018	SELL	$6.93 - $14.63 $10,637 - $22,457	-1,535 Reduced 1.2%	126,663 $889,000
Q1 2018 May 14, 2018	BUY	$8.71 - $14.82 $20,128 - $34,249	2,311 Added 1.84%	128,198 $1.82 Million
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $108,919 - $180,694	13,964 Added 12.48%	125,887 $1.1 Million
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $1.22 Million - $1.42 Million	111,923	111,923 $1.31 Million

227

88.3M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $882M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.